TrialJournal of Korean medical science2023

Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.

Heejoon Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.